La investigación clínica revela que el cannabidiol ayuda a mitigar el dolor crónico y la ansiedad, pero faltan dosis ...
Talking With Docs on MSN
What physicians need patients to understand about cannabidiol products
What physicians need patients to understand about cannabidiol products ...
A medically formulated THC and CBD treatment reduced agitation in a blinded trial involving people with late-stage dementia.
Durante años, el debate sobre el cannabis ha permanecido atrapado entre la discusión sobre su uso medicinal y el consumo para ...
El creciente interés de farmacias y agencias distribuidoras por comercializar derivados de cannabis medicinal llevó al ...
Read more about how standardized outcome measures and design parameters impact Fragile X Syndrome clinical trials in a new ...
Jia Yao Holdings prévoit de publier un bénéfice net après impôts compris entre 11 millions et 15 millions de yuans pour le premier semestre 2026, contre une perte nette de 22,2 millions ...
Research suggests cannabis suppresses REM sleep, raising questions about memory, emotion and the purpose of dreams.
In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.
Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses ...
Texas will ban delta-8, delta-10, THCP and other hemp products July 31. Here's what remains legal after the Supreme Court ...
Former acting DHS Secretary Chad Wolf urges Congress to investigate Chinese-linked actors' role in THC hemp products and illegal marijuana operations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results